Luisa Schwarzmüller

6PUBLICATIONS
77CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Jun 06, 2026
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model.

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Oct 02, 2025
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set.

Ute Distler, Han Byul Yoo, Oliver Kardell

|Apr 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Diana Drago-Garcia, Suvendu Giri, Rishita Chatterjee

|Dec 02, 2023
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.

Lukas Beumers, Efstathios-Iason Vlachavas, Simone Borgoni

Pageof 1

Frequent Collaborators

5 joint publications

Stefan Wiemann

4 joint publications

Yosef Yarden

3 joint publications

Birgitta E Michels

3 joint publications

Emre Sofyali